What is the current price for "When will the FDA approve Compass Pathways' COMP360 Psilocybin?"?

The leading outcome "No" is currently trading at 52.5% probability.

How many markets are available for "When will the FDA approve Compass Pathways' COMP360 Psilocybin?"?

There are 5 markets available for this event on Kalshi.

What is the trading volume for "When will the FDA approve Compass Pathways' COMP360 Psilocybin?"?

Trading volume data is not currently available.

BackKKALSHI

When will the FDA approve Compass Pathways' COMP360 Psilocybin?

Yes86%

Vol$0.00

Markets5

86%

TradeTrade on Kalshi

Event Group

EventKALSHI

Single EventKALSHIScience and Technology

When will the FDA approve Compass Pathways' COMP360 Psilocybin?

Name: When will the FDA approve Compass Pathways' COMP360 Psilocybin?
Start: 2026-07-10T09:28:19.833Z
End: 2026-08-09T09:28:19.833Z

Part of: When will the FDA approve Compass Pathways' COMP360 Psilocybin?

COMP360 Psilocybin for Treatment-Resistant Depression If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before X 1, 2027, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs. This market will close and expire early if the event occurs.

YesLeading Yes Probability

86%

VolTotal Volume

$0.00

Markets

Trade on Kalshi

When will the FDA approve Compass Pathways' COMP360 Psilocybin?

Yes

86%

Vol

$0.00

Markets

Trade

Market Price Graph

5 markets tracked

When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before 2028)

kalshi

No data available

All Markets(5)

Market	Price
When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before 2028)	86%
When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before October 2027)	82%
When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before July 2027)	72%
Will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression before Mar 1, 2027? (Before Mar 1, 2027)	48%
Will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression before Jan 1, 2027? (Before Jan 1, 2027)	31%

Markets (5)

Sort

KALSHIHealth

When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before 2028)

If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jan 1, 2028, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs.

When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before October 2027)

If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Oct 1, 2027, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs.

When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before July 2027)

If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jul 1, 2027, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs.

Will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression before Mar 1, 2027? (Before Mar 1, 2027)

If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Mar 1, 2027, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs.

Will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression before Jan 1, 2027? (Before Jan 1, 2027)

If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jan 1, 2027, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs.

When will the FDA approve Compass Pathways' COMP360 Psilocybin?

When will the FDA approve Compass Pathways' COMP360 Psilocybin?

When will the FDA approve Compass Pathways' COMP360 Psilocybin?

Market Price Graph

When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before 2028)

Rules & Resolution Criteria

Markets (5)

When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before 2028)

When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before October 2027)

When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before July 2027)

Will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression before Mar 1, 2027? (Before Mar 1, 2027)

Will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression before Jan 1, 2027? (Before Jan 1, 2027)

Share This Event